Contemporary methods of improving cognitive dysfunction in clinical depression

References

• World Health Organisation. Depression and other common mental disorders. Geneva: World Health Organisation; 2017. [cited 2018 Jan]. Available from http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf
   Google Scholar
• Rock PL, Roiser JP, Riedel WJ, et al. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44:2029–2040.
   PubMed Web of Science ®Google Scholar
• Jaeger J, Berns S, Uzelac S, et al. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006;145:39–48.
   PubMed Web of Science ®Google Scholar
• Gualtieri CT, Morgan DW. The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials. J Clin Psychiatry. 2008.
   PubMed Web of Science ®Google Scholar
• Cambridge OR, Knight MJ, Mills N, et al. The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: a systematic review. Psychiatry Res. 2018;269:157-171.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JZ, Woldeyohannes HO, et al. The impact of cognitive impairment on perceived workforce performance: results from the international mood disorders collaborative project. Compr Psychiatry. 2015;56:279–282. Epub 2014/12/03
   PubMed Web of Science ®Google Scholar
• Evans VC, Iverson GL, Yatham LN, et al. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review. J Clin Psychiatry. 2014;75:1359–1370. Epub 2015/01/01
   PubMed Web of Science ®Google Scholar
• MacKenzie LE, Uher R, Pavlova B. Cognitive performance in first-degree relatives of individuals with vs without major depressive disorder: a meta-analysis. JAMA psychiatry. 2018;76:297-305.
   Web of Science ®Google Scholar
• Joormann J, Vanderlind WM. Emotion regulation in depression the role of biased cognition and reduced cognitive control. Clin Psychol Sci. 2014;2:402–421.
   Google Scholar
• Joormann J, Gotlib IH. Updating the contents of working memory in depression: interference from irrelevant negative material. J Abnorm Psychol. 2008;117:182.
   PubMed Web of Science ®Google Scholar
• Bortolato B, Carvalho A, McIntyre R. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review. CNS Neurol Disord Drug Targets. 2015;13:1804–1818.
   Web of Science ®Google Scholar
• Hasselbalch BJ, Knorr U, Kessing LV. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord. 2011;134:20–31.
   PubMed Web of Science ®Google Scholar
• Knight MJ, Air T, Baune BT. The role of cognitive impairment in psychosocial functioning in remitted depression. J Affect Disord. 2018;235:129–134.
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, Kakar R, McIntyre RS.The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials.Int J Neuropsychopharmacol.2016;19:1-13.
   Web of Science ®Google Scholar
• Motter JN, Pimontel MA, Rindskopf D, et al. Computerized cognitive training and functional recovery in major depressive disorder: a meta-analysis. J Affect Disord. 2016;189:184–191.
   PubMed Web of Science ®Google Scholar
• Knight MJ, Baune BT. Cognitive dysfunction in major depressive disorder. Curr Opin Psychiatry. 2018;31:26–31.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Lee Y. Cognition in major depressive disorder: a ‘Systemically Important Functional Index’(SIFI). Curr Opin Psychiatry. 2016;29:48–55.
   PubMed Web of Science ®Google Scholar
• Erickson KI, Voss MW, Prakash RS, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci India Sect B Biol Sci. 2011;108:3017–3022.
   Google Scholar
• Sun M, Lanctot K, Herrmann N, et al. Exercise for cognitive symptoms in depression: a systematic review of interventional studies. Can J Psychiatry. 2018;63:115–128.
   PubMed Web of Science ®Google Scholar
• Roiser JP, Elliott R, Sahakian BJ. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology. 2012;37:117.
   PubMed Web of Science ®Google Scholar
• Bahar-Fuchs A, Clare L, Woods B. Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer‘s or vascular type: a review. Alzheimers Res Ther. 2013;5:35.
   PubMed Web of Science ®Google Scholar
• Twamley EW, Thomas KR, Burton CZ, et al. Compensatory cognitive training for people with severe mental illnesses in supported employment: a randomized controlled trial. Schizophr Res. 2017;203:41-48.
   Google Scholar
• MacQueen GM, Memedovich KA. Cognitive dysfunction in major depression and bipolar disorder: a ssessment and treatment options. Psychiatry Clin Neurosci. 2017;71:18–27.
   PubMed Web of Science ®Google Scholar
• Meusel L-AC, Hall GB, Fougere P, et al. Neural correlates of cognitive remediation in patients with mood disorders. Psychiatry Res Neuroimaging. 2013;214:142–152.
   Web of Science ®Google Scholar
• Knight MJ, Baune BT. Psychosocial dysfunction in major depressive disorder–rationale, design, and characteristics of the cognitive and emotional recovery training program for depression (CERT-D). Front Psychiatry. 2017;8:280.
   PubMed Web of Science ®Google Scholar
• Engvig A, Fjell AM, Westlye LT, et al. Effects of memory training on cortical thickness in the elderly. Neuroimage. 2010;52:1667–1676.
   PubMed Web of Science ®Google Scholar
• Knight MJ, Baune BT. Executive function and spatial cognition mediate psychosocial dysfunction in major depressive disorder. Front Psychiatry. 2018;9:539.
   PubMed Web of Science ®Google Scholar
• Knight MJ, Baune BT. Social cognitive abilities predict psychosocial dysfunction in major depressive disorder. Depress Anxiety. 2018;36:1–9.
   Web of Science ®Google Scholar
• Knight MJ, Baune BT. Executive subdomains are differentially associated with psychosocial outcomes in major depressive disorder. Front Psychiatry. 2018;9:309.
   PubMed Web of Science ®Google Scholar
• Weightman MJ, Air TM, Baune BT. A review of the role of social cognition in major depressive disorder. Front Psychiatry. 2014;5:179.
   PubMed Web of Science ®Google Scholar
• Air T, Weightman MJ, Baune BT. Symptom severity of depressive symptoms impacts on social cognition performance in current but not remitted major depressive disorder. Front Psychol. 2015;6:1118.
   PubMed Web of Science ®Google Scholar
• Penton-Voak IS, Bate H, Lewis G, et al. Effects of emotion perception training on mood in undergraduate students: randomised controlled trial. Br J Psychiatry. 2012;201:71–72.
   PubMed Web of Science ®Google Scholar
• Combs DR, Adams SD, Penn DL, et al. Social cognition and interaction training (SCIT) for inpatients with schizophrenia spectrum disorders: preliminary findings. Schizophr Res. 2007;91:112–116.
   PubMed Web of Science ®Google Scholar
• Roberts DL, Combs DR, Willoughby M, et al. A randomized, controlled trial of social cognition and interaction training (SCIT) for outpatients with schizophrenia spectrum disorders. Br J Clin Psychol. 2014;53:281–298.
   PubMed Web of Science ®Google Scholar
• Kandalaft MR, Didehbani N, Krawczyk DC, et al. Virtual reality social cognition training for young adults with high-functioning autism. J Autism Dev Disord. 2013;43:34–44.
   PubMed Web of Science ®Google Scholar
• Didehbani N, Allen T, Kandalaft M, et al. Virtual reality social cognition training for children with high functioning autism. Comput Human Behav. 2016;62:703–711.
   Web of Science ®Google Scholar
• Tranter R, Bell D, Gutting P, et al. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients. J Affect Disord. 2009;118:87–93.
   PubMed Web of Science ®Google Scholar
• Shiroma PR, Thuras P, Johns B, et al. Emotion recognition processing as early predictor of response to 8‐week citalopram treatment in late‐life depression. Int J Geriatr Psychiatry. 2014;29:1132–1139.
   PubMed Web of Science ®Google Scholar
• MacDonald K, MacDonald TM, Brüne M, et al. Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression. Psychoneuroendocrinology. 2013;38:2831–2843.
   PubMed Web of Science ®Google Scholar
• Berlim MT, Mcgirr A, Beaulieu -M-M, et al. Theory of mind in subjects with major depressive disorder: is it influenced by repetitive transcranial magnetic stimulation? World J Biol Psychiatry. 2012;13:474–479.
   PubMed Web of Science ®Google Scholar
• Brennan S, McLoughlin DM, O‘Connell R, et al. Anodal transcranial direct current stimulation of the left dorsolateral prefrontal cortex enhances emotion recognition in depressed patients and controls. J Clin Exp Neuropsychol. 2017;39:384–395.
   PubMed Web of Science ®Google Scholar
• Newby JM, McKinnon A, Kuyken W, et al. Systematic review and meta-analysis of transdiagnostic psychological treatments for anxiety and depressive disorders in adulthood. Clin Psychol Rev. 2015;40:91–110.
   PubMed Web of Science ®Google Scholar
• Porter R, Bourke C, Carter J, et al. No change in neuropsychological dysfunction or emotional processing during treatment of major depression with cognitive–behaviour therapy or schema therapy. Psychol Med. 2016;46:393–404.
   PubMed Web of Science ®Google Scholar
• Shou H, Yang Z, Satterthwaite TD, et al. Cognitive behavioral therapy increases amygdala connectivity with the cognitive control network in both MDD and PTSD. Neuroimage Clin. 2017;14:464–470.
   PubMed Web of Science ®Google Scholar
• Yang Z, Oathes DJ, Linn KA, et al. Cognitive behavioral therapy is associated with enhanced cognitive control network activity in major depression and posttraumatic stress disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:311–319.
   PubMedGoogle Scholar
• Alderman B, Olson R, Brush C, et al. MAP training: combining meditation and aerobic exercise reduces depression and rumination while enhancing synchronized brain activity. Transl Psychiatry. 2017;6:e726.
   Web of Science ®Google Scholar
• Goodkind MS, Gallagher‐Thompson D, Thompson LW, et al. The impact of executive function on response to cognitive behavioral therapy in late‐life depression. Int J Geriatr Psychiatry. 2016;31:334–339.
   PubMed Web of Science ®Google Scholar
• Dajani DR, Uddin LQ. Demystifying cognitive flexibility: implications for clinical and developmental neuroscience. Trends Neurosci. 2015;38:571–578.
   PubMed Web of Science ®Google Scholar
• van der Velden AM, Kuyken W, Wattar U, et al. A systematic review of mechanisms of change in mindfulness-based cognitive therapy in the treatment of recurrent major depressive disorder. Clin Psychol Rev. 2015;37:26–39.
   PubMed Web of Science ®Google Scholar
• Bostanov V, Keune PM, Kotchoubey B, et al. Event-related brain potentials reflect increased concentration ability after mindfulness-based cognitive therapy for depression: a randomized clinical trial. Psychiatry Res. 2012;199:174–180.
   PubMed Web of Science ®Google Scholar
• J Porter R, Douglas K, Jordan J, et al. Psychological treatments for cognitive dysfunction in major depressive disorder: current evidence and perspectives §. CNS Neurol Disord Drug Targets. 2014;13:1677–1692.
   PubMed Web of Science ®Google Scholar
• Da Silva SK, Wiener C, Ghisleni G, et al. Effects of cognitive-behavioral therapy on neurotrophic factors in patients with major depressive disorder. Braz J Psychiatry. 2018.
   Google Scholar
• Yaffe K, Barnes D, Nevitt M, et al. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med. 2001;161:1703–1708.
   PubMed Web of Science ®Google Scholar
• Zheng G, Xia R, Zhou W, et al. Aerobic exercise ameliorates cognitive function in older adults with mild cognitive impairment: a systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2016;50:1443–1450.
   PubMed Web of Science ®Google Scholar
• Kelly ME, Loughrey D, Lawlor BA, et al. The impact of exercise on the cognitive functioning of healthy older adults: a systematic review and meta-analysis. Ageing Res Rev. 2014;16:12–31.
   PubMed Web of Science ®Google Scholar
• Farioli-Vecchioli S, Sacchetti S, Di Robilant NV, et al. The role of physical exercise and omega-3 fatty acids in depressive illness in the elderly. Curr Neuropharmacol. 2018;16:308–326.
   PubMed Web of Science ®Google Scholar
• Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. Bmj. 2001;322:763.
   PubMed Web of Science ®Google Scholar
• Nasstasia Y, Baker AL, Halpin SA, et al. Pilot study of an exercise intervention for depressive symptoms and associated cognitive-behavioral factors in young adults with major depression. J Nerv Ment Dis. 2017;205:647–655.
   PubMed Web of Science ®Google Scholar
• Déry N, Pilgrim M, Gibala M, et al. Adult hippocampal neurogenesis reduces memory interference in humans: opposing effects of aerobic exercise and depression. Front Neurosci. 2013;7:66.
   PubMed Web of Science ®Google Scholar
• Oertel-Knöchel V, Mehler P, Thiel C, et al. Effects of aerobic exercise on cognitive performance and individual psychopathology in depressive and schizophrenia patients. Eur Arch Psychiatry Clin Neurosci. 2014;264:589–604.
   PubMed Web of Science ®Google Scholar
• Chan AS, Wong QY, Sze SL, et al. A Chinese Chan-based mind–body intervention for patients with depression. J Affect Disord. 2012;142:283–289.
   PubMed Web of Science ®Google Scholar
• Lavretsky H, Alstein LL, Olmstead RE, et al. Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial. Am J Geriatr Psychiatry. 2011;19:839–850.
   PubMed Web of Science ®Google Scholar
• Sharma V, Das S, Mondal S, et al. Effect of Sahaj Yoga on neuro-cognitive functions in patients suffering from major depression. Ind J Physiol Pharmacol. 2006;50:375.
   PubMedGoogle Scholar
• Halappa NG, Thirthalli J, Varambally S, et al. Improvement in neurocognitive functions and serum brain-derived neurotrophic factor levels in patients with depression treated with antidepressants and yoga. Indian J Psychiatry. 2018;60:32.
   PubMed Web of Science ®Google Scholar
• Pascoe MC, Bauer IE. A systematic review of randomised control trials on the effects of yoga on stress measures and mood. J Psychiatr Res. 2015;68:270–282.
   PubMed Web of Science ®Google Scholar
• Harinath K, Malhotra AS, Pal K, et al. Effects of Hatha yoga and Omkar meditation on cardiorespiratory performance, psychologic profile, and melatonin secretion. J Altern Complement Med. 2004;10:261–268.
   PubMed Web of Science ®Google Scholar
• Veith RC, Lewis N, Linares OA, et al. Sympathetic nervous system activity in major depression: basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry. 1994;51:411–422.
   PubMed Web of Science ®Google Scholar
• Tolahunase MR, Sagar R, Faiq M, et al. Yoga-and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: a randomized controlled trial. Restor Neurol Neurosci. 2018;36:1–20.
   PubMed Web of Science ®Google Scholar
• Hötting K, Röder B. Beneficial effects of physical exercise on neuroplasticity and cognition. Neurosci Biobehav Rev. 2013;37:2243–2257.
   PubMed Web of Science ®Google Scholar
• Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008;33:88.
   PubMed Web of Science ®Google Scholar
• Mori A, Okamoto Y, Okada G, et al. Effects of behavioural activation on the neural circuit related to intrinsic motivation. BJPsych Open. 2018;4:317–323.
   PubMed Web of Science ®Google Scholar
• Brondino N, Rocchetti M, Fusar‐Poli L, et al. A systematic review of cognitive effects of exercise in depression. Acta Psychiatr Scand. 2017;135:285–295.
   PubMed Web of Science ®Google Scholar
• Salagre E, Sole B, Tomioka Y, et al. Treatment of neurocognitive symptoms in unipolar depression: a systematic review and future perspectives. J Affect Disord. 2017;221:205–221.
   PubMed Web of Science ®Google Scholar
• Dale E, Pehrson AL, Jeyarajah T, et al. Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function. CNS Spectr. 2016;21:143–161.
   PubMed Web of Science ®Google Scholar
• Baune BT, Brignone M, Larsen KG. A network meta-analysis comparing effects of various antidepressant classes on the digit symbol substitution test (DSST) as a measure of cognitive dysfunction in patients with major depressive disorder. Int J Neuropsychopharmacol. 2018;21:97–107.
   PubMed Web of Science ®Google Scholar
• Baune BT, Renger L. Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression – a systematic review. Psychiatry Res. 2014;219:25–50.
   PubMed Web of Science ®Google Scholar
• Lozupone M, La Montagna M, D‘Urso F, et al. Pharmacotherapy for the treatment of depression in patients with alzheimer‘s disease: a treatment-resistant depressive disorder. Expert Opin Pharmacother. 2018;19:823–842. Epub 2018/05/05
   PubMed Web of Science ®Google Scholar
• Munro CA, Longmire CF, Drye LT, et al. Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. Am J Geriatr Psychiatry. 2012;20:1036–1044. Epub 2012/10/04
   PubMed Web of Science ®Google Scholar
• An H, Choi B, Park KW, et al. The effect of escitalopram on mood and cognition in depressive Alzheimer’s disease subjects. J Alzheimers Dis. 2017;55:727–735. Epub 2016/10/08
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Lee Y, Zhou AJ, et al. The efficacy of psychostimulants in major depressive episodes: a systematic review and meta-analysis. J Clin Psychopharmacol. 2017;37:412–418. Epub 2017/06/08
   PubMed Web of Science ®Google Scholar
• Madhoo M, Keefe RS, Roth RM, et al. Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder. Neuropsychopharmacology. 2014;39:1388–1398. Epub 2013/12/07
   PubMed Web of Science ®Google Scholar
• Kaser M, Deakin JB, Michael A, et al. Modafinil improves episodic memory and working memory cognition in patients with remitted depression: a double-blind, randomized, Placebo-controlled study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2:115–122. Epub 2017/03/17
   PubMedGoogle Scholar
• Lavretsky H, Reinlieb M, St Cyr N, et al. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Am J Psychiatry. 2015;172:561–569. Epub 2015/02/14
   PubMed Web of Science ®Google Scholar
• DeBattista C, Lembke A, Solvason HB, et al. A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol. 2004;24:87–90. Epub 2004/01/08
   PubMed Web of Science ®Google Scholar
• Samaras K, Lutgers HL, Kochan NA, et al. The impact of glucose disorders on cognition and brain volumes in the elderly: the sydney memory and ageing study. Age (Dordr). 2014;36:977–993. Epub 2014/01/10
   PubMedGoogle Scholar
• Yogi-Morren D, Galioto R, Strandjord SE, et al. Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome. Cardiovasc Psychiatry Neurol. 2014;2014:656341. Epub 2014/07/25
   PubMedGoogle Scholar
• Mansur RB, Lee Y, Subramaniapillai M, et al. Cognitive dysfunction and metabolic comorbidities in mood disorders: a repurposing opportunity for glucagon-like peptide 1 receptor agonists? Neuropharmacology. 2018;136:335–342. Epub 2018/02/27
   PubMed Web of Science ®Google Scholar
• Weina H, Yuhu N, Christian H, et al. Liraglutide attenuates the depressive- and anxiety-like behaviour in the corticosterone induced depression model via improving hippocampal neural plasticity. Brain Res. 2018;1694:55–62. Epub 2018/05/01
   PubMed Web of Science ®Google Scholar
• Mansur RB, Ahmed J, Cha DS, et al. Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study. J Affect Disord. 2017;207:114–120. Epub 2016/10/11
   PubMed Web of Science ®Google Scholar
• Maes M, Yirmiya R, Noraberg J, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 2009;24:27–53.
   PubMed Web of Science ®Google Scholar
• Mocking RJT, Harmsen I, Assies J, et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. 2016;6:e756.
   Web of Science ®Google Scholar
• Antypa N, Smelt AHM, Strengholt A, et al. Effects of omega-3 fatty acid supplementation on mood and emotional information processing in recovered depressed individuals. J Psychopharmacol. 2012;26:738–743.
   PubMed Web of Science ®Google Scholar
• Knochel C, Voss M, Gruter F, et al. Omega 3 fatty acids: novel neurotherapeutic targets for cognitive dysfunction in mood disorders and schizophrenia? Curr Neuropharmacol. 2015;13:663–680.
   PubMed Web of Science ®Google Scholar
• Berk M, Dean O, Drexhage H, et al. Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. BMC Med. 2013;11:74-91.
   Web of Science ®Google Scholar
• Baune BT. Are non-steroidal anti-inflammatory drugs clinically suitable for the treatment of symptoms in depression-associated inflammation? Curr Top Behav Neurosci. 2017;31:303–319. Epub 2016/07/14.
   PubMedGoogle Scholar
• Baune BT. Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention? Curr Opin Psychiatry. 2015;28:148–154.
   PubMed Web of Science ®Google Scholar
• Mendlewicz J, Kriwin P, Oswald P, et al. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol. 2006;21:227–231.
   PubMed Web of Science ®Google Scholar
• Quinn AL, Dean OM, Davey CG, et al. Youth depression alleviation-augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin. Early Interv Psychiatry. 2018;12:45–54.
   PubMed Web of Science ®Google Scholar
• Sicard P, Delemasure S, Korandji C, et al. Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats. Free Radic Res. 2008;42:226–236.
   PubMed Web of Science ®Google Scholar
• Skvarc DR, Berk M, Byrne LK, et al. Post-operative cognitive dysfunction: an exploration of the inflammatory hypothesis and novel therapies. Neurosci Biobehav Rev. 2018;84:116–133.
   PubMed Web of Science ®Google Scholar
• Maes M. Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression. Metab Brain Dis. 2012;27:405–413.
   PubMed Web of Science ®Google Scholar
• Eyre HA, Stuart MJ, Baune BT. A phase-specific neuroimmune model of clinical depression. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:265–274.
   PubMed Web of Science ®Google Scholar
• Fourrier C, Sampson E, Mills NT, et al. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo. Trials. 2018;19:447-461.
   Web of Science ®Google Scholar
• Murrough JW, Losifescu DV, Chang LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013;170:1134–1142.
   PubMed Web of Science ®Google Scholar
• Murrough JW, Wan LB, Iacoviello B, et al. Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology (Berl). 2014;231:481–488.
   Web of Science ®Google Scholar
• Lee Y, Syeda K, Maruschak NA, et al. A new perspective on the anti-suicide effects with ketamine treatment a procognitive effect. J Clin Psychopharmacol. 2016;36:50–56.
   PubMed Web of Science ®Google Scholar
• Shiroma PR, Albott CS, Johns B, et al. Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression. Int J Neuropsychopharmacol. 2014;17:1805–1813.
   PubMed Web of Science ®Google Scholar
• Wolff K, Winstock AR. Ketamine – from medicine to misuse. Cns Drugs. 2006;20:199–218.
   PubMed Web of Science ®Google Scholar
• Berk M, Malhi GS, Gray LJ, et al. The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci. 2013;34:167–177.
   PubMed Web of Science ®Google Scholar
• Skvarc DR, Dean OM, Byrne LK, et al. The effect of N-acetylcysteine (NAC) on human cognition – a systematic review. Neurosci Biobehav Rev. 2017;78:44–56.
   PubMed Web of Science ®Google Scholar
• Berk M, Dean OM, Cotton SM, et al. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, Placebo-controlled trial. J Clin Psychiatry. 2014;75:628–U95.
   PubMed Web of Science ®Google Scholar
• Hasebe K, Gray L, Bortolasci C, et al. Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor. Acta Neuropsychiatr. 2017;29:337–346.
   PubMed Web of Science ®Google Scholar
• Dean OM, Bush AI, Copolov DL, et al. Effects of N-acetyl cysteine on cognitive function in bipolar disorder. Psychiatry Clin Neurosci. 2012;66:514–517.
   PubMed Web of Science ®Google Scholar
• Rapado-Castro M, Dodd S, Bush AI, et al. Cognitive effects of adjunctive N-acetyl cysteine in psychosis. Psychol Med. 2017;47:866–876.
   PubMed Web of Science ®Google Scholar
• Bortolato B, Miskowiak KW, Kohler CA, et al. Cognitive remission: a novel objective for the treatment of major depression? BMC Med. 2016;14:9-27.
   Web of Science ®Google Scholar
• Rosenblat JD, McIntyre RS. Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials. J Affect Disord. 2018;227:219–225.
   PubMed Web of Science ®Google Scholar
• Gironacci MM, Vicario A, Cerezo G, et al. The depressor axis of the renin-angiotensin system and brain disorders: a translational approach. Clin Sci. 2018;132:1021–1038.
   PubMed Web of Science ®Google Scholar
• Vian J, Pereira C, Chavarria V, et al. The renin-angiotensin system: a possible new target for depression. BMC Med. 2017;15:144-157.
   Web of Science ®Google Scholar
• Santos RAS, Sampaio WO, Alzamora AC, et al. The ACE2/angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7). Physiol Rev. 2018;98:505–553.
   PubMed Web of Science ®Google Scholar
• Padberg F, George MS. Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp Neurol. 2009;219:2–13.
   PubMed Web of Science ®Google Scholar
• Ilieva IP, Alexopoulos GS, Dubin MJ, et al. Age-related repetitive transcranial magnetic stimulation effects on executive function in depression: a systematic review. Am J Geriatr Psychiatry. 2018;26:334–346.
   PubMed Web of Science ®Google Scholar
• Wajdik C, Claypoole KH, Fawaz W, et al. No change in neuropsychological functioning after receiving repetitive transcranial magnetic stimulation treatment for major depression. J ECT. 2014;30:320–324.
   PubMed Web of Science ®Google Scholar
• Naim-Feil J, Bradshaw JL, Sheppard DM, et al. Neuromodulation of attentional control in major depression: a pilot deepTMS study. Neural Plast. 2016;10.
   PubMed Web of Science ®Google Scholar
• Hoppner J, Schulz M, Irmisch G, et al. Antidepressant efficacy of two different rTMS procedures – high frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation. Eur Arch Psychiatry Clin Neurosci. 2003;253:103–109.
   PubMed Web of Science ®Google Scholar
• Mogg A, Pluck G, Eranti SV, et al. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression. Psychol Med. 2008;38:323–333.
   PubMed Web of Science ®Google Scholar
• Iimori T, Nakajima S, Miyazaki T, et al. Effectiveness of the prefrontal repetitive transcranial magnetic stimulation on cognitive profiles in depression, schizophrenia, and Alzheimer‘s disease: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2019;88:31–40.
   PubMed Web of Science ®Google Scholar
• Liebetanz D, Nitsche MA, Tergau F, et al. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain. 2002;125:2238–2247.
   PubMed Web of Science ®Google Scholar
• Fritsch B, Reis J, Martinowich K, et al. Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron. 2010;66:198–204.
   PubMed Web of Science ®Google Scholar
• Hill AT, Fitzgerald PB, Hoy KE. Effects of anodal transcranial direct current stimulation on working memory: a systematic review and meta-analysis of findings from healthy and neuropsychiatric populations. Brain Stimul. 2016;9:197–208.
   PubMed Web of Science ®Google Scholar
• Rygiel K. Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer‘s disease? An overview of research evidence in the elderly patient population. J Postgrad Med. 2016;62:242–248.
   PubMed Web of Science ®Google Scholar
• Levi Marpillat N, Macquin-Mavier I, Tropeano AI, et al. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013;31:1073–1082.
   PubMed Web of Science ®Google Scholar
• Wilkinson ST, Wright D, Fasula MK, et al. Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression. Psychother Psychosom. 2017;86:162–167.
   PubMed Web of Science ®Google Scholar
• Sack AT, Kadosh RC, Schuhmann T, et al. Optimizing functional accuracy of TMS in cognitive studies: a comparison of methods. J Cogn Neurosci. 2009;21:207–221.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Best MW, Bowie CR, et al. The THINC-integrated tool (THINC-it) screening assessment for cognitive dysfunction: validation in patients with major depressive disorder. J Clin Psychiatry. 2017;78:873–881. Epub 2017/09/01
   PubMed Web of Science ®Google Scholar
• Knight MJ, Fourrier C, Lyrtzis E, et al. Cognitive deficits in the THINC-integrated tool (THINC-it) are associated with psychosocial dysfunction in patients with major depressive disorder. J Clin Psychiatry. 2018;80.
   PubMed Web of Science ®Google Scholar
• Ott CV, Bjertrup AJ, Jensen JH, et al. Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools. J Affect Disord. 2016;190:607–615.
   PubMed Web of Science ®Google Scholar